‘Middlemen’ Markups Are Penalizing Patients, Says AAM

Cash Prices For Generic Drugs Are Substantially Higher Than Manufacturer Prices

Infographic showing atorvastatin markup
AAM says generics manufacturers do not have the same control over their supply chain as branded drugs • Source: Association For Accessible Medicines
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products